{"id":"https://openalex.org/W2129290879","doi":"https://doi.org/10.1177/2045125312451270","title":"Hallucinogen-persisting perception disorder","display_name":"Hallucinogen-persisting perception disorder","publication_year":2012,"publication_date":"2012-06-17","ids":{"openalex":"https://openalex.org/W2129290879","doi":"https://doi.org/10.1177/2045125312451270","mag":"2129290879","pmid":"https://pubmed.ncbi.nlm.nih.gov/23983976","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3736944"},"language":"en","primary_location":{"id":"doi:10.1177/2045125312451270","doi":"https://doi.org/10.1177/2045125312451270","is_oa":false,"landing_page_url":"https://doi.org/10.1177/2045125312451270","pdf_url":null,"source":{"id":"https://openalex.org/S2765027927","display_name":"Therapeutic Advances in Psychopharmacology","issn_l":"2045-1253","issn":["2045-1253","2045-1261"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/articles/PMC3736944","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032404851","display_name":"Leo Hermle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leo Hermle","raw_affiliation_strings":["Department of Psychiatry, Christophsbad, G\u00f6ppingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Christophsbad, G\u00f6ppingen, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049662077","display_name":"Melanie Simon","orcid":"https://orcid.org/0000-0002-9713-9214","observed_orcids":["https://orcid.org/0000-0002-9713-9214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melanie Simon","raw_affiliation_strings":["Department of Psychiatry, Christophsbad, G\u00f6ppingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Christophsbad, G\u00f6ppingen, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045262289","display_name":"Martin Ruchsow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Ruchsow","raw_affiliation_strings":["Department of Psychiatry, Christophsbad, Faurndauer Str. 6 \u2013 28, 73035 G\u00f6ppingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Christophsbad, Faurndauer Str. 6 \u2013 28, 73035 G\u00f6ppingen, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103474374","display_name":"Martin Geppert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Geppert","raw_affiliation_strings":["Department of Psychiatry, Christophsbad, G\u00f6ppingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Christophsbad, G\u00f6ppingen, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2650,"currency":"USD","value_usd":2650},"apc_paid":null,"fwci":3.2586,"has_fulltext":false,"cited_by_count":73,"citation_normalized_percentile":{"value":0.90998106,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"2","issue":"5","first_page":"199","last_page":"205"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.9154999852180481,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.9154999852180481,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13397","display_name":"Hallucinations in medical conditions","score":0.06109999865293503,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.010700000450015068,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hallucinogen-persisting-perception-disorder","display_name":"hallucinogen persisting perception disorder","score":0.9269999861717224},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.8529999852180481},{"id":"https://openalex.org/keywords/visual-disturbances","display_name":"visual disturbances","score":0.5809999704360962},{"id":"https://openalex.org/keywords/halo-effect","display_name":"halo effect","score":0.546999990940094},{"id":"https://openalex.org/keywords/afterimages","display_name":"afterimages","score":0.6169999837875366},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.6790000200271606},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9100000262260437},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.7089999914169312},{"id":"https://openalex.org/keywords/mood-stabilization","display_name":"mood stabilization","score":0.7760000228881836},{"id":"https://openalex.org/keywords/anticonvulsant-therapy","display_name":"anticonvulsant therapy","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.8633331060409546},{"id":"https://openalex.org/C2779871769","wikidata":"https://www.wikidata.org/wiki/Q23118","display_name":"Lysergic acid diethylamide","level":4,"score":0.8000654578208923},{"id":"https://openalex.org/C124315065","wikidata":"https://www.wikidata.org/wiki/Q194270","display_name":"Hallucinogen","level":2,"score":0.7467472553253174},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5635726451873779},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.5149734616279602},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.507197380065918},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.4952923357486725},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.448426753282547},{"id":"https://openalex.org/C2778807096","wikidata":"https://www.wikidata.org/wiki/Q900394","display_name":"Dissociative","level":2,"score":0.4140767455101013},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3919546902179718},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.301416277885437},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.1804429292678833},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1099088191986084},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1177/2045125312451270","doi":"https://doi.org/10.1177/2045125312451270","is_oa":false,"landing_page_url":"https://doi.org/10.1177/2045125312451270","pdf_url":null,"source":{"id":"https://openalex.org/S2765027927","display_name":"Therapeutic Advances in Psychopharmacology","issn_l":"2045-1253","issn":["2045-1253","2045-1261"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Psychopharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2743270","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3736944","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3736944","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3736944","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Psychopharmacol","raw_type":"Text"},{"id":"pmid:23983976","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23983976","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic advances in psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2743270","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3736944","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7900000214576721}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W104966348","https://openalex.org/W192963154","https://openalex.org/W1837446435","https://openalex.org/W1965812297","https://openalex.org/W1967205222","https://openalex.org/W1967681543","https://openalex.org/W1967887881","https://openalex.org/W1984929847","https://openalex.org/W2002178209","https://openalex.org/W2008071452","https://openalex.org/W2013734228","https://openalex.org/W2028456442","https://openalex.org/W2039087930","https://openalex.org/W2043768758","https://openalex.org/W2047111528","https://openalex.org/W2055312975","https://openalex.org/W2059195881","https://openalex.org/W2062649784","https://openalex.org/W2067384745","https://openalex.org/W2078583994","https://openalex.org/W2086828044","https://openalex.org/W2088342863","https://openalex.org/W2093328760","https://openalex.org/W2095483365","https://openalex.org/W2106188235","https://openalex.org/W2114629758","https://openalex.org/W2120411943","https://openalex.org/W2128917867","https://openalex.org/W2132883073","https://openalex.org/W2134541433","https://openalex.org/W2150903999","https://openalex.org/W2152569564","https://openalex.org/W2159011576","https://openalex.org/W2165924165","https://openalex.org/W2227171113","https://openalex.org/W2312475727","https://openalex.org/W2314380100","https://openalex.org/W2325057627","https://openalex.org/W2331687003","https://openalex.org/W2331958871","https://openalex.org/W2332406580","https://openalex.org/W2334528135","https://openalex.org/W2344031085","https://openalex.org/W2398555336","https://openalex.org/W2418086577","https://openalex.org/W2663937641","https://openalex.org/W2799091751","https://openalex.org/W2913028290","https://openalex.org/W3022868799","https://openalex.org/W4249275496"],"related_works":["https://openalex.org/W2184278236","https://openalex.org/W7117984165","https://openalex.org/W4387216276","https://openalex.org/W3195370529","https://openalex.org/W2464973388","https://openalex.org/W2376514477","https://openalex.org/W7207645866","https://openalex.org/W4229061392","https://openalex.org/W4414162243","https://openalex.org/W2749574850"],"abstract_inverted_index":{"A":[0],"33-year-old":[1],"female":[2],"patient":[3],"developed":[4],"a":[5,17,84],"hallucinogen-persisting":[6],"perception":[7,29],"disorder":[8],"(HPPD)":[9],"after":[10,27],"lysergic":[11],"acid":[12],"diethylamide":[13],"(LSD)":[14],"abuse":[15],"for":[16],"year":[18],"at":[19],"the":[20,79,89],"age":[21],"of":[22,30,38,91],"18.":[23],"Specifically,":[24],"she":[25],"reported":[26],"images,":[28],"movement":[31],"in":[32,88],"her":[33],"peripheral":[34],"visual":[35,66],"fields,":[36],"blurring":[37],"small":[39],"patterns,":[40],"halo":[41],"effects,":[42,78],"and":[43,45,51,76],"macro-":[44],"micropsia.":[46],"Previous":[47],"treatment":[48,90],"with":[49,62],"antidepressants":[50],"risperidone":[52],"failed":[53],"to":[54],"ameliorate":[55],"these":[56,64],"symptoms.":[57],"Upon":[58],"commencing":[59],"drug":[60],"therapy":[61],"lamotrigine,":[63],"complex":[65],"disturbances":[67],"receded":[68],"almost":[69],"completely.":[70],"Based":[71],"on":[72],"its":[73],"hypothesized":[74],"neuroprotective":[75],"mood-stabilizing":[77],"antiepileptic":[80],"lamotrigine":[81],"may":[82],"offer":[83],"promising":[85],"new":[86],"approach":[87],"HPPD.":[92]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2016-06-24T00:00:00"}